Comparison of JAK inhibitors and biologics with respect to pain reduction in patients with rheumatoid arthritis: data from the KOBIO registry

Background/Aims: To compare the pain-reducing efficacy of Janus kinase inhibitors (JAKis) and biologic disease-modifying antirheumatic drugs (bDMARDs) in patients with rheumatoid arthritis (RA). Methods: Patients with RA enrolled in the Korean College of Rheumatology Biologics and Targeted Therapy (KOBIO) registry were grouped according to use of JAKis, TNFis, and non-TNFi bDMARDs. The primary outcome was to compare the changes in pain on a numeric rating scale (NRS, range 0-10) between enrolment and first follow-up. Logistic regression analysis was performed to identify the factors associated with a low pain NRS score (< 2) and retention at the 1-year follow-up. Results: The analysis included 2,415 patients with RA in the JAKis (n = 422), TNFis (n = 1,148), and non-TNFi bDMARDs groups (n = 845). The change in pain NRS was significantly greater in the JAKis group than in the TNFis group (2.8 ± 2.5 vs. 2.3 ± 2.9, respectively; p < 0.01). The adjusted mean additional pain reduction was significantly greater in the JAKis than in the TNFis group (-0.42, 95% confidence interval [CI]: -0.73 to -0.10). The adjusted odds ratio (OR) for achieving a pain NRS score < 2 with initial drug retention at 1 year follow-up was significantly lower in the TNFis (OR = 0.515; 95% CI: 0.406-0.652) and non-TNFi bDMARDs (OR = 0.586; 95% CI: 0.458-0.751) groups than in the JAKis group. Conclusions: Among patients who achieved treatment response and remained on therapy, JAKis were associated with greater improvement in pain control than TNFis.

Authors

Institutions

Publication Details

Journal
The Korean Journal of Internal Medicine
Published
2026-11-13
DOI
https://doi.org/10.3904/kjim.2025.298
Primary Topic
Rheumatoid Arthritis Research and Therapies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Comparison of JAK inhibitors and biologics with respect to pain reduction in patients with rheumatoid arthritis: data from the KOBIO registry

Hong Ki Min, Howook Jeon
4 links
The Korean Journal of Internal Medicine
Rheumatoid Arthritis Research and Therapies
article

Comparison of JAK inhibitors and biologics with respect to pain reduction in patients with rheumatoid arthritis: data from the KOBIO registry

Hong Ki Min, Howook Jeon
article en

Abstract

Background/Aims: To compare the pain-reducing efficacy of Janus kinase inhibitors (JAKis) and biologic disease-modifying antirheumatic drugs (bDMARDs) in patients with rheumatoid arthritis (RA). Methods: Patients with RA enrolled in the Korean College of Rheumatology Biologics and Targeted Therapy (KOBIO) registry were grouped according to use of JAKis, TNFis, and non-TNFi bDMARDs. The primary outcome was to compare the changes in pain on a numeric rating scale (NRS, range 0-10) between enrolment and first follow-up. Logistic regression analysis was performed to identify the factors associated with a low pain NRS score (< 2) and retention at the 1-year follow-up. Results: The analysis included 2,415 patients with RA in the JAKis (n = 422), TNFis (n = 1,148), and non-TNFi bDMARDs groups (n = 845). The change in pain NRS was significantly greater in the JAKis group than in the TNFis group (2.8 ± 2.5 vs. 2.3 ± 2.9, respectively; p < 0.01). The adjusted mean additional pain reduction was significantly greater in the JAKis than in the TNFis group (-0.42, 95% confidence interval [CI]: -0.73 to -0.10). The adjusted odds ratio (OR) for achieving a pain NRS score < 2 with initial drug retention at 1 year follow-up was significantly lower in the TNFis (OR = 0.515; 95% CI: 0.406-0.652) and non-TNFi bDMARDs (OR = 0.586; 95% CI: 0.458-0.751) groups than in the JAKis group. Conclusions: Among patients who achieved treatment response and remained on therapy, JAKis were associated with greater improvement in pain control than TNFis.

The Korean Journal of Internal Medicine
Konkuk University (KR), Konkuk University Medical Center (KR), The Catholic University of Korea Uijeongbu St. Mary's Hospital (KR), Catholic University of Korea (KR)
Good health and well-being
Rheumatoid Arthritis Research and Therapies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon